This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Huppertz B. The anatomy of the normal placenta. J Clin Pathol. 2008;61:1296-302; DOI:10.1136/jcp.2008.055277.HuppertzBThe anatomy of the normal placentaJ Clin Pathol200861129630210.1136/jcp.2008.05527718755720Open DOISearch in Google Scholar
Aplin JD, Myers JE, Timms K, Westwood M. Tracking placental development in health and disease. Nat Rev Endocrinol. 2020;16:479-94; DOI:10.1038/s41574-020-0372-6.AplinJDMyersJETimmsKWestwoodMTracking placental development in health and diseaseNat Rev Endocrinol2020164799410.1038/s41574-020-0372-632601352Open DOISearch in Google Scholar
Fukuchi Y, Nakajima H, Sugiyama D, Hirose I, Kitamura T, Tsuji K. Human Placenta-Derived Cells Have Mesenchymal Stem/Progenitor Cell Potential. Stem Cells. 2004;22:649-58; DOI:10.1634/stemcells.22-5-649.FukuchiYNakajimaHSugiyamaDHiroseIKitamuraTTsujiKHuman Placenta-Derived Cells Have Mesenchymal Stem/Progenitor Cell PotentialStem Cells2004226495810.1634/stemcells.22-5-64915342929Open DOISearch in Google Scholar
Huang Q, Yang Y, Luo C, Wen Y, Liu R, Li S, Chen T, Sun H, Tang L. An efficient protocol to generate placental chorionic plate-derived mesenchymal stem cells with superior proliferative and immunomodulatory properties. Stem Cell Res Ther. 2019;10:301; DOI:10.1186/ s13287-019-1405-8.HuangQYangYLuoCWenYLiuRLiSChenTSunHTangLAn efficient protocol to generate placental chorionic plate-derived mesenchymal stem cells with superior proliferative and immunomodulatory propertiesStem Cell Res Ther20191030110.1186/s13287-019-1405-8679637131623677Open DOISearch in Google Scholar
Parolini O, Alviano F, Bagnara GP, Bilic G, Bühring H-J, Evangelista M, Hennerbichler S, Liu B, Magatti M, Mao N, Miki T, Marongiu F, Nakajima H, Nikaido T, Portmann-Lanz CB, Sankar V, Soncini M, Stadler G, Surbek D, Takahashi TA, Redl H, Sakuragawa N, Wolbank S, Zeisberger S, Zisch A, Strom SC. Concise Review: Isolation and Characterization of Cells from Human Term Placenta: Outcome of the First International Workshop on Placenta Derived Stem Cells. Stem Cells. 2008;26:300-11; DOI:10.1634/ stemcells.2007-0594.ParoliniOAlvianoFBagnaraGPBilicGBühringH-JEvangelistaMHennerbichlerSLiuBMagattiMMaoNMikiTMarongiuFNakajimaHNikaidoTPortmann-LanzCBSankarVSonciniMStadlerGSurbekDTakahashiTARedlHSakuragawaNWolbankSZeisbergerSZischAStromSCConcise Review: Isolation and Characterization of Cells from Human Term Placenta: Outcome of the First International Workshop on Placenta Derived Stem CellsStem Cells2008263001110.1634/stemcells.2007-059417975221Open DOISearch in Google Scholar
Papait A, Vertua E, Magatti M, Ceccariglia S, De Munari S, Silini AR, Sheleg M, Ofir R, Parolini O. Mesenchymal Stromal Cells from Fetal and Maternal Placenta Possess Key Similarities and Differences: Potential Implications for Their Applications in Regenerative Medicine. Cells. 2020;9:127; DOI:10.3390/cells9010127.PapaitAVertuaEMagattiMCeccarigliaSDe MunariSSiliniARShelegMOfirRParoliniOMesenchymal Stromal Cells from Fetal and Maternal Placenta Possess Key Similarities and Differences: Potential Implications for Their Applications in Regenerative MedicineCells2020912710.3390/cells9010127701720531935836Open DOISearch in Google Scholar
Komaki M, Numata Y, Morioka C, Honda I, Tooi M, Yokoyama N, Ayame H, Iwasaki K, Taki A, Oshima N, Morita I. Exosomes of human placenta-derived mesenchymal stem cells stimulate angiogenesis. Stem Cell Res Ther. 2017;8:219; DOI:10.1186/s13287-017-0660-KomakiMNumataYMoriokaCHondaITooiMYokoyamaNAyameHIwasakiKTakiAOshimaNMoritaIExosomes of human placenta-derived mesenchymal stem cells stimulate angiogenesisStem Cell Res Ther2017821910.1186/s13287-017-0660-Open DOISearch in Google Scholar
Magatti M, Pianta S, Silini A, Parolini O. Isolation, culture, and phenotypic characterization of mesenchymal stromal cells from the amniotic membrane of the human term placenta. Methods Mol. Biol. 2016;1416:23344; DOI:10.1007/978-1-4939-3584-0_13.MagattiMPiantaSSiliniAParoliniOIsolation, culture, and phenotypic characterization of mesenchymal stromal cells from the amniotic membrane of the human term placentaMethods Mol. Biol201614162334410.1007/978-1-4939-3584-0_1327236675Open DOISearch in Google Scholar
Shen C, Yang C, Xu S, Zhao H. Comparison of osteogenic differentiation capacity in mesenchymal stem cells derived from human amniotic membrane (AM), umbilical cord (UC), chorionic membrane (CM), and decidua (DC). Cell Biosci. 2019;9:17; DOI:10.1186/s13578-019-0281-3.ShenCYangCXuSZhaoHComparison of osteogenic differentiation capacity in mesenchymal stem cells derived from human amniotic membrane (AM), umbilical cord (UC), chorionic membrane (CM), and decidua (DC)Cell Biosci201991710.1186/s13578-019-0281-3637154530792848Open DOISearch in Google Scholar
Ma J, Wu J, Han L, Jiang X, Yan L, Hao J, Wang H. Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord, and chorionic plate under serum-free condition. Stem Cell Res Ther. 2019;10:19; DOI:10.1186/s13287-018-1104-x.MaJWuJHanLJiangXYanLHaoJWangHComparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord, and chorionic plate under serum-free conditionStem Cell Res Ther2019101910.1186/s13287-018-1104-x633047230635045Open DOISearch in Google Scholar
Kim MJ, Shin KS, Jeon JH, Lee DR, Shim SH, Kim JK, Cha DH, Yoon TK, Kim GJ. Human chorionic-plate-derived mesenchymal stem cells and Wharton’s jelly-derived mesenchymal stem cells: A comparative analysis of their potential as placenta-derived stem cells. Cell Tissue Res. 2011;346:53-64; DOI:10.1007/s00441-011-1249-8.KimMJShinKSJeonJHLeeDRShimSHKimJKChaDHYoonTKKimGJHuman chorionic-plate-derived mesenchymal stem cells and Wharton’s jelly-derived mesenchymal stem cells: A comparative analysis of their potential as placenta-derived stem cellsCell Tissue Res2011346536410.1007/s00441-011-1249-821987220Open DOISearch in Google Scholar
Silini AR, Masserdotti A, Papait A, Parolini O. Shaping the future of perinatal cells: Lessons from the past and interpretations of the present. Front Bioeng Biotechnol. 2019;7:75; DOI:10.3389/fbioe.2019.00075.SiliniARMasserdottiAPapaitAParoliniOShaping the future of perinatal cells: Lessons from the past and interpretations of the presentFront Bioeng Biotechnol201977510.3389/fbioe.2019.00075646793831024907Open DOISearch in Google Scholar
Abumaree MH, Abomaray FM, Alshabibi MA, AlAskar AS, Kalionis B. Immunomodulatory properties of human placental mesenchymal stem/stromal cells. Placenta. 2017;59:87–95; DOI:10.1016/j. placenta.2017.04.003.AbumareeMHAbomarayFMAlshabibiMAAlAskarASKalionisBImmunomodulatory properties of human placental mesenchymal stem/stromal cellsPlacenta201759879510.1016/j.placenta.2017.04.00328411943Open DOISearch in Google Scholar
Avercenc-Léger L, Guerci P, Virion JM, Cauchois G, Hupont S, Rahouadj R, Magdalou J, Stoltz JF, Bensoussan D, Huselstein C, Reppel L. Umbilical cord-derived mesenchymal stromal cells: Predictive obstetric factors for cell proliferation and chondrogenic differentiation. Stem Cell Res Ther. 2017;8:161; DOI:10.1186/s13287-017-0609-z.Avercenc-LégerLGuerciPVirionJMCauchoisGHupontSRahouadjRMagdalouJStoltzJFBensoussanDHuselsteinCReppelLUmbilical cord-derived mesenchymal stromal cells: Predictive obstetric factors for cell proliferation and chondrogenic differentiationStem Cell Res Ther2017816110.1186/s13287-017-0609-z549735828676126Open DOISearch in Google Scholar
Winkler T, Perka C, von Roth P, Agres AN, Plage H, Preininger B, Pumberger M, Geissler S, Hagai EL, Ofir R, Pinzur L, Eyal E, Stoltenburg-Didinger G, Meisel C, Consentius C, Streitz M, Reinke P, Duda GN, Volk HD. Immunomodulatory placental-expanded, mesenchymal stromal cells improve muscle function following hip arthroplasty. J Cachexia Sarcopenia Muscle. 2018;9:880-897; DOI:10.1002/jcsm.12316.WinklerTPerkaCvonRoth PAgresANPlageHPreiningerBPumbergerMGeisslerSHagaiELOfirRPinzurLEyalEStoltenburg-DidingerGMeiselCConsentiusCStreitzMReinkePDudaGNVolkHDImmunomodulatory placental-expanded, mesenchymal stromal cells improve muscle function following hip arthroplastyJ Cachexia Sarcopenia Muscle2018988089710.1002/jcsm.12316620459530230266Open DOISearch in Google Scholar
Kong CM, Subramanian A, Biswas A, Stunkel W, Chong YS, Bongso A, Fong CY. Changes in Stemness Properties, Differentiation Potential, Oxidative Stress, Senescence and Mitochondrial Function in Wharton’s Jelly Stem Cells of Umbilical Cords of Mothers with Gestational Diabetes Mellitus. Stem Cell Rev Reports. 2019;15:415-426; DOI:10.1007/ s12015-019-9872-y.KongCMSubramanianABiswasAStunkelWChongYSBongsoAFongCYChanges in Stemness Properties, Differentiation Potential, Oxidative Stress, Senescence and Mitochondrial Function in Wharton’s Jelly Stem Cells of Umbilical Cords of Mothers with Gestational Diabetes MellitusStem Cell Rev Reports20191541542610.1007/s12015-019-9872-y30645713Open DOISearch in Google Scholar
Khalifeh Soltani S, Forogh B, Ahmadbeigi N, Hadizadeh Kharazi H, Fallahzadeh K, Kashani L, Karami M, Kheyrollah Y, Vasei M. Safety and efficacy of allogenic placental mesenchymal stem cells for treating knee osteoarthritis: a pilot study. Cytotherapy. 2019;21:54-63; DOI:10.1016/j.jcyt.2018.11.003.KhalifehSoltani SForoghBAhmadbeigiNHadizadehKharazi HFallahzadehKKashaniLKaramiMKheyrollahYVaseiMSafety and efficacy of allogenic placental mesenchymal stem cells for treating knee osteoarthritis: a pilot studyCytotherapy201921546310.1016/j.jcyt.2018.11.00330522806Open DOISearch in Google Scholar
Ji LL, Song G, Jiang LM, Liu Y, Ding ZJ, Zhuang XY, Chen X. Evaluation of conditioned medium from placenta-derived mesenchymal stem cells as a storage medium for avulsed teeth: An in vitro study. Dent Traumatol. 2021;37:73-80; DOI:10.1111/edt.12599.JiLLSongGJiangLMLiuYDingZJZhuangXYChenXEvaluation of conditioned medium from placenta-derived mesenchymal stem cells as a storage medium for avulsed teeth: An in vitro studyDent Traumatol202137738010.1111/edt.1259932794607Open DOISearch in Google Scholar
Zeng X, Tang Y, Hu K, Jiao W, Ying L, Zhu L, Liu J, Xu J. Three-week topical treatment with placenta-derived mesenchymal stem cells hydrogel in a patient with diabetic foot ulcer: A case report. Med (United States). 2017;96:e9212; DOI:10.1097/MD.0000000000009212.ZengXTangYHuKJiaoWYingLZhuLLiuJXuJThree-week topical treatment with placenta-derived mesenchymal stem cells hydrogel in a patient with diabetic foot ulcer: A case reportMed (United States)201796e921210.1097/MD.0000000000009212575817029390468Open DOISearch in Google Scholar
Levy JA, Marchand M, Iorio L, Cassini W, Zahalsky MP. Determining the feasibility of managing erectile dysfunction in humans with placental-derived stem cells. J Am Osteopath Assoc. 2016;116:e1-5; DOI:10.7556/ jaoa.2016.007.LevyJAMarchandMIorioLCassiniWZahalskyMPDetermining the feasibility of managing erectile dysfunction in humans with placental-derived stem cellsJ Am Osteopath Assoc2016116e1510.7556/jaoa.2016.00726745574Open DOISearch in Google Scholar
Levy JA, Marchand M, Iorio L, Zribi G, Zahalsky MP. Effects of stem cell treatment in human patients with peyronie disease. J Am Osteopath Assoc. 2015;115:e8-13; DOI:10.7556/jaoa.2015.124.LevyJAMarchandMIorioLZribiGZahalskyMPEffects of stem cell treatment in human patients with peyronie diseaseJ Am Osteopath Assoc2015115e81310.7556/jaoa.2015.12426414724Open DOISearch in Google Scholar
Han YM, Park JM, Choi YS, Jin H, Lee YS, Han NY, Lee H, Hahm KB. The efficacy of human placenta-derived mesenchymal stem cells on radiation enteropathy along with proteomic biomarkers predicting a favorable response. Stem Cell Res Ther. 2017;8:105; DOI:10.1186/ s13287-017-0559-5.HanYMParkJMChoiYSJinHLeeYSHanNYLeeHHahmKBThe efficacy of human placenta-derived mesenchymal stem cells on radiation enteropathy along with proteomic biomarkers predicting a favorable responseStem Cell Res Ther2017810510.1186/s13287-017-0559-5541432328464953Open DOISearch in Google Scholar
Baughman RP, Culver DA, Jankovi V, Fischkoff S, Brockway G, Lower EE. Placenta-derived mesenchymal-like cells (PDA-001) as therapy for chronic pulmonary sarcoidosis: A phase 1 study. Sarcoidosis Vasc Diffus Lung Dis. 2015;32:106-14.BaughmanRPCulverDAJankoviVFischkoffSBrockwayGLowerEEPlacenta-derived mesenchymal-like cells (PDA-001) as therapy for chronic pulmonary sarcoidosis: A phase 1 studySarcoidosis Vasc Diffus Lung Dis20153210614Search in Google Scholar
Chambers DC, Enever D, Ilic N, Sparks L, Whitelaw K, Ayres J, Yerkovich ST, Khalil D, Atkinson KM, Hopkins PMA. A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis. Respirology. 2014;19:1013-8; DOI:10.1111/resp.12343.ChambersDCEneverDIlicNSparksLWhitelawKAyresJYerkovichSTKhalilDAtkinsonKMHopkinsPMAA phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosisRespirology2014191013810.1111/resp.1234325039426Open DOISearch in Google Scholar
Lin SC, Liou YM, Ling TY, Chuang YH, Chiang BL. Placenta-derived mesenchymal stem cells reduce the interleukin-5 level experimentally in children with asthma. Int J Med Sci. 2019;16:1430-1438; DOI:10.7150/ ijms.33590.LinSCLiouYMLingTYChuangYHChiangBLPlacenta-derived mesenchymal stem cells reduce the interleukin-5 level experimentally in children with asthmaInt J Med Sci2019161430143810.7150/ijms.33590681820031673233Open DOISearch in Google Scholar
Park M, Banga JP, Kim GJ, Kim MY, Lew H. Human placenta-derived mesenchymal stem cells ameliorate orbital adipogenesis in female mice models of Graves’ ophthalmopathy. Stem Cell Res Ther. 2019;10:246; DOI:10.1186/s13287-019-1348-0.ParkMBangaJPKimGJKimMYLewHHuman placenta-derived mesenchymal stem cells ameliorate orbital adipogenesis in female mice models of Graves’ ophthalmopathyStem Cell Res Ther20191024610.1186/s13287-019-1348-0668825431399042Open DOISearch in Google Scholar
Choi YJ, Koo JB, Kim HY, Seo JW, Lee EJ, Kim WR, Cho JY, Hahm KB, Hong SP, Kim DH, Yoo JH. Umbilical cord/placenta-derived mesenchymal stem cells inhibit fibrogenic activation in human intestinal myofibroblasts via inhibition of myocardin-related transcription factor A. Stem Cell Res Ther. 2019;10:291; DOI:10.1186/s13287-019-1385-8.ChoiYJKooJBKimHYSeoJWLeeEJKimWRChoJYHahmKBHongSPKimDHYooJHUmbilical cord/placenta-derived mesenchymal stem cells inhibit fibrogenic activation in human intestinal myofibroblasts via inhibition of myocardin-related transcription factor AStem Cell Res Ther20191029110.1186/s13287-019-1385-8675744231547873Open DOISearch in Google Scholar
Jiang R, Han Z, Zhuo G, Qu X, Li X, Wang X, Shao Y, Yang S, Han ZC. Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: A pilot study. Front Med China. 2011;5:94-100; DOI:10.1007/ s11684-011-0116-z.JiangRHanZZhuoGQuXLiXWangXShaoYYangSHanZCTransplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: A pilot studyFront Med China201159410010.1007/s11684-011-0116-z21681681Open DOISearch in Google Scholar
Kumar P, Becker JC, Gao K, Carney RP, Lankford L, Keller BA, Herout K, Lam KS, Farmer DL, Wang A. Neuroprotective effect of placenta-derived mesenchymal stromal cells: role of exosomes. FASEB J. 2019;33:58365849; DOI:10.1096/fj.201800972R.KumarPBeckerJCGaoKCarneyRPLankfordLKellerBAHeroutKLamKSFarmerDLWangANeuroprotective effect of placenta-derived mesenchymal stromal cells: role of exosomesFASEB J2019335836584910.1096/fj.201800972R646392130753093Open DOISearch in Google Scholar
Bier A, Berenstein P, Kronfeld N, Morgoulis D, Ziv-Av A, Goldstein H, Kazimirsky G, Cazacu S, Meir R, Popovtzer R, Dori A, Brodie C. Placenta-derived mesenchymal stromal cells and their exosomes exert therapeutic effects in Duchenne muscular dystrophy. Biomaterials. 2018;174:67-78; DOI:10.1016/j.biomaterials.2018.04.055.BierABerensteinPKronfeldNMorgoulisDZiv-AvAGoldsteinHKazimirskyGCazacuSMeirRPopovtzerRDoriABrodieCPlacenta-derived mesenchymal stromal cells and their exosomes exert therapeutic effects in Duchenne muscular dystrophyBiomaterials2018174677810.1016/j.biomaterials.2018.04.05529783118Open DOISearch in Google Scholar
Lublin FD, Bowen JD, Huddlestone J, Kremenchutzky M, Carpenter A, Corboy JR, Freedman MS, Krupp L, Paulo C, Hariri RJ, Fischkoff SA. Human placenta-derived cells(pda-001) for the treatment of adults with multiple sclerosis: Arandomized,placebo-controlled, multiple-dose study. Mult Scler Relat Disord. 2014;3:696-704; DOI:10.1016/j. msard.2014.08.002.LublinFDBowenJDHuddlestoneJKremenchutzkyMCarpenterACorboyJRFreedmanMSKruppLPauloCHaririRJFischkoffSAHuman placenta-derived cells(pda-001) for the treatment of adults with multiple sclerosis: Arandomized,placebo-controlled, multiple-dose studyMult Scler Relat Disord2014369670410.1016/j.msard.2014.08.00225891548Open DOISearch in Google Scholar
Liu J, Lu X, Lou Y, Cai Y, Cui W, Wang J, Nie P, Chen L, Li B, Luo P. Xenogeneic Transplantation of Human Placenta-Derived Mesenchymal Stem Cells Alleviates Renal Injury and Reduces Inflammation in a Mouse Model of Lupus Nephritis. Biomed Res Int. 2019;2019:9370919; DOI:10.1155/2019/9370919.LiuJLuXLouYCaiYCuiWWangJNiePChenLLiBLuoPXenogeneic Transplantation of Human Placenta-Derived Mesenchymal Stem Cells Alleviates Renal Injury and Reduces Inflammation in a Mouse Model of Lupus NephritisBiomed Res Int20192019937091910.1155/2019/9370919642105130941373Open DOISearch in Google Scholar
Hashemi SS, Mohammadi AA, Kabiri H, Hashempoor MR, Mahmoodi M, Amini M, Mehrabani D. The healing effect of Wharton’s jelly stem cells seeded on biological scaffold in chronic skin ulcers: A randomized clinical trial. J Cosmet Dermatol. 2019;18:1961-1967; DOI:10.1111/jocd.12931.HashemiSSMohammadiAAKabiriHHashempoorMRMahmoodiMAminiMMehrabaniDThe healing effect of Wharton’s jelly stem cells seeded on biological scaffold in chronic skin ulcers: A randomized clinical trialJ Cosmet Dermatol2019181961196710.1111/jocd.1293131127705Open DOISearch in Google Scholar
Bartolucci J, Verdugo FJ, González PL, Larrea RE, Abarzua E, Goset C, Rojo P, Palma I, Lamich R, Pedreros PA, Valdivia G, Lopez VM, Nazzal C, Alcayaga-Miranda F, Cuenca J, Brobeck MJ, Patel AN, Figueroa FE, Khoury M. Safety and efficacy of the intravenous infusion of umbilical cord mesenchymal stem cells in patients with heart failure: A phase 1/2 randomized controlled trial (RIMECARD trial [Randomized clinical trial of intravenous infusion umbilical cord mesenchymal stem cells on cardiopathy]). Circ Res. 2017;121:1192-1204; DOI:10.1161/ CIRCRESAHA.117.310712.BartolucciJVerdugoFJGonzálezPLLarreaREAbarzuaEGosetCRojoPPalmaILamichRPedrerosPAValdiviaGLopezVMNazzalCAlcayaga-MirandaFCuencaJBrobeckMJPatelANFigueroaFEKhouryMSafety and efficacy of the intravenous infusion of umbilical cord mesenchymal stem cells in patients with heart failure: A phase 1/2 randomized controlled trial (RIMECARD trial [Randomized clinical trial of intravenous infusion umbilical cord mesenchymal stem cells on cardiopathy])Circ Res20171211192120410.1161/CIRCRESAHA.117.310712637205328974553Open DOISearch in Google Scholar
He X, Wang Q, Zhao Y, Zhang H, Wang B, Pan J, Li J, Yu H, Wang L, Dai J, Wang D. Effect of Intramyocardial Grafting Collagen Scaffold With Mesenchymal Stromal Cells in Patients With Chronic Ischemic Heart Disease: A Randomized Clinical Trial. JAMA Netw Open. 2020;3:e2016236; DOI:10.1001/jamanetworkopen.2020.16236.HeXWangQZhaoYZhangHWangBPanJLiJYuHWangLDaiJWangDEffect of Intramyocardial Grafting Collagen Scaffold With Mesenchymal Stromal Cells in Patients With Chronic Ischemic Heart Disease: A Randomized Clinical TrialJAMA Netw Open20203e201623610.1001/jamanetworkopen.2020.16236748986332910197Open DOISearch in Google Scholar
Matas J, Orrego M, Amenabar D, Infante C, Tapia-Limonchi R, Cadiz MI, Alcayaga-Miranda F, González PL, Muse E, Khoury M, Figueroa FE, Espinoza F. Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial. Stem Cells Transl Med. 2019;8:215-224; DOI:10.1002/sctm.18-0053.MatasJOrregoMAmenabarDInfanteCTapia-LimonchiRCadizMIAlcayaga-MirandaFGonzálezPLMuseEKhouryMFigueroaFEEspinozaFUmbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II TrialStem Cells Transl Med2019821522410.1002/sctm.18-0053639236730592390Open DOISearch in Google Scholar
Chen C, Qu Z, Yin X, Shang C, Ao Q, Gu Y, Liu Y. Efficacy of umbilical cord-derived mesenchymal stem cell-based therapy for osteonecrosis of the femoral head: A three-year follow-up study. Mol Med Rep. 2016;14:4209-4215; DOI:10.3892/mmr.2016.5745.ChenCQuZYinXShangCAoQGuYLiuYEfficacy of umbilical cord-derived mesenchymal stem cell-based therapy for osteonecrosis of the femoral head: A three-year follow-up studyMol Med Rep2016144209421510.3892/mmr.2016.5745510196527634376Open DOISearch in Google Scholar
Wang L, Huang S, Li S, Li M, Shi J, Bai W, Wang Q, Zheng L, Liu Y. Efficacy and safety of umbilical cord mesenchymal stem cell therapy for rheumatoid arthritis patients: A prospective phase I/II study. Drug Des Devel Ther. 2019;13:4331-4340; DOI:10.2147/DDDT.S225613.WangLHuangSLiSLiMShiJBaiWWangQZhengLLiuYEfficacy and safety of umbilical cord mesenchymal stem cell therapy for rheumatoid arthritis patients: A prospective phase I/II studyDrug Des Devel Ther2019134331434010.2147/DDDT.S225613693083631908418Open DOISearch in Google Scholar
Liang J, Zhang H, Kong W, Deng W, Wang D, Feng X, Zhao C, Hua B, Wang H, Sun L. Safety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: A long-term retrospective study. Stem Cell Res Ther. 2018;9:312; DOI:10.1186/ s13287-018-1053-4.LiangJZhangHKongWDengWWangDFengXZhaoCHuaBWangHSunLSafety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: A long-term retrospective studyStem Cell Res Ther2018931210.1186/s13287-018-1053-4623687330428931Open DOISearch in Google Scholar
Deng D, Zhang P, Guo Y, Lim TO. A randomised double-blind, placebo-controlled trial of allogeneic umbilical cord-derived mesenchymal stem cell for lupus nephritis. Ann Rheum Dis. 2017;76:1436-1439; DOI:10.1136/annrheumdis-2017-211073.DengDZhangPGuoYLimTOA randomised double-blind, placebo-controlled trial of allogeneic umbilical cord-derived mesenchymal stem cell for lupus nephritisAnn Rheum Dis2017761436143910.1136/annrheumdis-2017-21107328478399Open DOISearch in Google Scholar
Zhang J, Lv S, Liu X, Song B, Shi L. Umbilical cord mesenchymal stem cell treatment for Crohn’s disease: A randomized controlled clinical trial. Gut Liver. 2018;12:73-78; DOI:10.5009/gnl17035.ZhangJLvSLiuXSongBShiLUmbilical cord mesenchymal stem cell treatment for Crohn’s disease: A randomized controlled clinical trialGut Liver201812737810.5009/gnl17035575368728873511Open DOISearch in Google Scholar
Riordan NH, Morales I, Fernández G, Allen N, Fearnot NE, Leckrone ME, Markovich DJ, Mansfield D, Avila D, Patel AN, Kesari S, Paz Rodriguez J. Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis. J Transl Med. 2018;16:57; DOI:10.1186/s12967-018-1433-7.RiordanNHMoralesIFernándezGAllenNFearnotNELeckroneMEMarkovichDJMansfieldDAvilaDPatelANKesariSPazRodriguez JClinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosisJ Transl Med2018165710.1186/s12967-018-1433-7584526029523171Open DOISearch in Google Scholar
Sun Q, Huang Z, Han F, Zhao M, Cao R, Zhao D, Hong L, Na N, Li H, Miao B, Hu J, Meng F, Peng Y, Sun Q. Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: Pilot results of a multicenter randomized controlled trial. J Transl Med. 2018;16:52; DOI:10.1186/s12967-018-1422-x.SunQHuangZHanFZhaoMCaoRZhaoDHongLNaNLiHMiaoBHuJMengFPengYSunQAllogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: Pilot results of a multicenter randomized controlled trialJ Transl Med2018165210.1186/s12967-018-1422-x584253229514693Open DOISearch in Google Scholar
Shi M, Liu Z, Wang Y, Xu R, Sun Y, Zhang M, Yu X, Wang H, Meng L, Su H, Jin L, Wang FS. A Pilot Study of Mesenchymal Stem Cell Therapy for Acute Liver Allograft Rejection. Stem Cells Transl Med. 2017;6:2053-2061; DOI:10.1002/sctm.17-0134.ShiMLiuZWangYXuRSunYZhangMYuXWangHMengLSuHJinLWangFSA Pilot Study of Mesenchymal Stem Cell Therapy for Acute Liver Allograft RejectionStem Cells Transl Med201762053206110.1002/sctm.17-0134570251429178564Open DOISearch in Google Scholar
Cao Y, Sun H, Zhu H, Zhu X, Tang X, Yan G, Wang J, Bai D, Wang J, Wang L, Zhou Q, Wang H, Dai C, Ding L, Xu B, Zhou Y, Hao J, Dai J, Hu Y. Allogeneic cell therapy using umbilical cord MSCs on collagen scaffolds for patients with recurrent uterine adhesion: A phase i clinical trial. Stem Cell Res Ther. 2018;9:192; DOI:10.1186/s13287-018-0904-3.CaoYSunHZhuHZhuXTangXYanGWangJBaiDWangJWangLZhouQWangHDaiCDingLXuBZhouYHaoJDaiJHuYAllogeneic cell therapy using umbilical cord MSCs on collagen scaffolds for patients with recurrent uterine adhesion: A phase i clinical trialStem Cell Res Ther2018919210.1186/s13287-018-0904-3604245029996892Open DOISearch in Google Scholar
Ding L, Yan G, Wang B, Xu L, Gu Y, Ru T, Cui X, Lei L, Liu J, Sheng X, Wang B, Zhang C, Yang Y, Jiang R, Zhou J, Kong N, Lu F, Zhou H, Zhao Y, Chen B, Hu Y, Dai J, Sun H. Transplantation of UC-MSCs on collagen scaffold activates follicles in dormant ovaries of POF patients with long history of infertility. Sci China Life Sci. 2018;61:1554-1565; DOI:10.1007/ s11427-017-9272-2.DingLYanGWangBXuLGuYRuTCuiXLeiLLiuJShengXWangBZhangCYangYJiangRZhouJKongNLuFZhouHZhaoYChenBHuYDaiJSunHTransplantation of UC-MSCs on collagen scaffold activates follicles in dormant ovaries of POF patients with long history of infertilitySci China Life Sci2018611554156510.1007/s11427-017-9272-229546669Open DOISearch in Google Scholar
He X, Ai S, Guo W, Yang Y, Wang Z, Jiang D, Xu X. Umbilical cord-derived mesenchymal stem (stromal) cells for treatment of severe sepsis: aphase 1 clinical trial. Transl Res. 2018;199:52-61; DOI:10.1016/j. trsl.2018.04.006.HeXAiSGuoWYangYWangZJiangDXuXUmbilical cord-derived mesenchymal stem (stromal) cells for treatment of severe sepsis: aphase 1 clinical trialTransl Res2018199526110.1016/j.trsl.2018.04.00630044959Open DOISearch in Google Scholar
Meng F, Xu R, Wang S, Xu Z, Zhang C, Li Y, Yang T, Shi L, Fu J, Jiang T, Huang L, Zhao P, Yuan X, Fan X, Zhang JY, Song J, Zhang D, Jiao Y, Liu L, Zhou C, Maeurer M, Zumla A, Shi M, Wang FS. Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial. Signal Transduct Target Ther. 2020;5:172; DOI:10.1038/ s41392-020-00286-5.MengFXuRWangSXuZZhangCLiYYangTShiLFuJJiangTHuangLZhaoPYuanXFanXZhangJYSongJZhangDJiaoYLiuLZhouCMaeurerMZumlaAShiMWangFSHuman umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trialSignal Transduct Target Ther2020517210.1038/s41392-020-00286-5745016332855385Open DOISearch in Google Scholar
Shu L, Niu C, Li R, Huang T, Wang Y, Huang M, Ji N, Zheng Y, Chen X, Shi L, Wu M, Deng K, Wei J, Wang X, Cao Y, Yan J, Feng G. Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells. Stem Cell Res Ther. 2020;11:361; DOI:10.1186/s13287-020-01875-5.ShuLNiuCLiRHuangTWangYHuangMJiNZhengYChenXShiLWuMDengKWeiJWangXCaoYYanJFengGTreatment of severe COVID-19 with human umbilical cord mesenchymal stem cellsStem Cell Res Ther20201136110.1186/s13287-020-01875-5743254032811531Open DOISearch in Google Scholar
